Jaguar Health (JAGX) Free Cash Flow (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Free Cash Flow of $8.9 million for Q1 2026, up 221.23% year-over-year from $2.8 million in Q1 2025, and up 308.1% quarter-over-quarter from -$4.3 million in Q4 2025.
Jaguar Health (JAGX) Free Cash Flow (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Free Cash Flow for 13 consecutive years, with $8.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Free Cash Flow rose 221.23% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at -$6.4 million (up 78.82% YoY), while the FY2025 annual figure was -$22.5 million, up 23.43% from the prior year.
- Free Cash Flow improved to $8.9 million in Q1 2026 per JAGX's latest filing, from -$4.3 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $8.9 million in Q1 2026 and bottomed at -$11.6 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$6.4 million across 5 years, with a median of -$7.3 million in 2025.
- Annual changes were most pronounced in 2023 — Free Cash Flow sank 45.9% — and 2026, when it surged 221.23%.
- Jaguar Health's Free Cash Flow stood at -$5.1 million in 2022, then plunged by 45.9% to -$7.4 million in 2023, then retreated by 0.85% to -$7.5 million in 2024, then soared by 43.27% to -$4.3 million in 2025, then jumped by 308.1% to $8.9 million in 2026.
- Business Quant data shows JAGX's Free Cash Flow at $8.9 million in Q1 2026, -$4.3 million in Q4 2025, and -$4.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Jaguar Health | 447,549.24 | -9.62 Mn | 19.11 Mn | 8.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.87 Mn |
| Mar 31, 2026 | 8.87 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Dec 31, 2025 | -4.26 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Sep 30, 2025 | -4.85 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Jun 30, 2025 | -6.20 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Mar 31, 2025 | -7.31 Mn |
| Dec 31, 2024 | -7.51 Mn |
| Dec 31, 2024 | -7.51 Mn |
| Sep 30, 2024 | -6.66 Mn |
| Sep 30, 2024 | -6.66 Mn |
| Jun 30, 2024 | -8.92 Mn |
| Jun 30, 2024 | -8.92 Mn |
| Mar 31, 2024 | -6.31 Mn |
| Mar 31, 2024 | -6.31 Mn |
| Dec 31, 2023 | -7.45 Mn |
| Dec 31, 2023 | -7.45 Mn |